NSE:SUNPHARMA (India)
Â
Ordinary Shares
₹
1540.10
(+1.14%)
Apr 22
Current and historical daily PE Ratio for Sun Pharmaceuticals Industries Ltd (
) from 1995 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sun Pharmaceuticals Industries stock (NSE:SUNPHARMA) PE ratio as of Apr 23 2024 is 41.05.
More Details
Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) PE Ratio (TTM) Chart
Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
Total 1261
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Sun Pharmaceuticals Industries PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-23 | 41.5 | 2024-02-20 | 41.5 |
| 2024-04-22 | 41.5 | 2024-02-19 | 41.2 |
| 2024-04-19 | 41.0 | 2024-02-16 | 40.7 |
| 2024-04-18 | 40.9 | 2024-02-15 | 40.7 |
| 2024-04-17 | 41.4 | 2024-02-14 | 41.0 |
| 2024-04-16 | 41.4 | 2024-02-13 | 41.6 |
| 2024-04-15 | 41.5 | 2024-02-12 | 41.4 |
| 2024-04-12 | 41.5 | 2024-02-09 | 41.4 |
| 2024-04-11 | 43.2 | 2024-02-08 | 40.4 |
| 2024-04-10 | 43.2 | 2024-02-07 | 40.3 |
| 2024-04-09 | 43.2 | 2024-02-06 | 39.8 |
| 2024-04-08 | 43.1 | 2024-02-05 | 39.5 |
| 2024-04-05 | 43.4 | 2024-02-02 | 38.2 |
| 2024-04-04 | 43.6 | 2024-02-01 | 38.0 |
| 2024-04-03 | 43.7 | 2024-01-31 | 38.2 |
| 2024-04-02 | 43.7 | 2024-01-30 | 37.0 |
| 2024-04-01 | 43.9 | 2024-01-29 | 37.8 |
| 2024-03-29 | 43.7 | 2024-01-26 | 36.9 |
| 2024-03-28 | 43.7 | 2024-01-25 | 36.9 |
| 2024-03-27 | 43.2 | 2024-01-24 | 37.3 |
| 2024-03-26 | 43.1 | 2024-01-23 | 37.1 |
| 2024-03-25 | 43.4 | 2024-01-22 | 36.0 |
| 2024-03-22 | 43.4 | 2024-01-19 | 36.0 |
| 2024-03-21 | 42.2 | 2024-01-18 | 36.0 |
| 2024-03-20 | 41.8 | 2024-01-17 | 35.0 |
| 2024-03-19 | 41.7 | 2024-01-16 | 35.4 |
| 2024-03-18 | 42.4 | 2024-01-15 | 35.8 |
| 2024-03-15 | 41.7 | 2024-01-12 | 35.7 |
| 2024-03-14 | 42.3 | 2024-01-11 | 35.5 |
| 2024-03-13 | 42.0 | 2024-01-10 | 35.7 |
| 2024-03-12 | 42.7 | 2024-01-09 | 35.7 |
| 2024-03-11 | 43.0 | 2024-01-08 | 35.2 |
| 2024-03-08 | 43.3 | 2024-01-05 | 35.0 |
| 2024-03-07 | 43.3 | 2024-01-04 | 35.4 |
| 2024-03-06 | 43.2 | 2024-01-03 | 35.0 |
| 2024-03-05 | 42.4 | 2024-01-02 | 34.9 |
| 2024-03-04 | 41.8 | 2024-01-01 | 34.0 |
| 2024-03-01 | 42.0 | 2023-12-29 | 34.0 |
| 2024-02-29 | 42.5 | 2023-12-28 | 34.0 |
| 2024-02-28 | 42.4 | 2023-12-27 | 35.2 |
| 2024-02-27 | 42.7 | 2023-12-26 | 35.0 |
| 2024-02-26 | 42.0 | 2023-12-25 | 34.9 |
| 2024-02-23 | 42.1 | 2023-12-22 | 34.9 |
| 2024-02-22 | 42.0 | 2023-12-21 | 34.6 |
| 2024-02-21 | 41.6 | 2023-12-20 | 34.6 |
Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sun Pharmaceuticals Industries Ltd
ISIN : INE044A01036
Share Class Description:
NSE:SUNPHARMA: Ordinary SharesCompare
Compare
Traded in other countries / regions
SUNPHARMA.India IPO Date
1995-02-08Description
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers